Geert Cauwenbergh, President & CEO at RXi Pharmaceuticals Corp (RXII), bought 2,000 shares at $1.25 ($2K) on 2015-02-10, disclosed to the SEC on 2015-02-11.
Open-market purchase of $2k RXII by President & CEO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.22 | 200 | $244 | 9.8% |
| 2 | $1.24 | 644 | $799 | 32.1% |
| 3 | $1.25 | 1,156 | $1K | 58.1% |
| Total | $1.24 avg | 2,000 | $2K | 100% |
| Filing → |
| RXII | BUY | 2017-06-22 | $6K | — | Filing → |
| RXII | BUY | 2017-04-26 | $7K | — | Filing → |
| RXII | BUY | 2017-03-20 | $8K | — | Filing → |